The problem arises when systems blur distinctions in ways that confuse patients and strain teams. The real fault line in ...

In the CAPItello-291 trial of capivasertib plus fulvestrant, 73% of patients had already received a CDK4/6 inhibitor. As ...

The FDA approved a pill version of the GLP-1 receptor agonist semaglutide (Wegovy), making it the first oral GLP-1 agent ...

Medicaid programs made more than $200 million in improper payments to healthcare providers between 2021 and 2022 for people ...

The U.S. government has signed health deals with at least nine African countries, part of its new approach to global health ...

The public's views of measles, mumps, and rubella (MMR) vaccine safety and effectiveness have dropped, as has willingness to ...

Arizona/Utah: The large outbreak on the Arizona-Utah border continues to grow, with 190 cases in Arizona (14 new cases) and ...

Science Signaling retracted a 2017 paper that linked a specific amyloid form (amyloid-beta 56) to tau pathology after an ...

Concurrently, low state immunization levels pose a significant and immediate risk, particularly for measles, which is ...

At the San Antonio Breast Cancer Symposium, investigators reported findings from a retrospective study exploring whether ...